The embryo-like model could help scientists test new drugs, create stem cells for transplants and research blood disorders ...

Novel regimen GO-4, combining melphalan, BCNU, hydroxocobalamin, ascorbic acid, and autologous stem cells shows manageable adverse reactions and a strong signal of efficacy in patients with BRCA-relat ...

Backed by GV and Arch Venture Partners, Pelage Pharmaceuticals is advancing a first-of-its-kind topical gel designed to ...

Elania is one of 59 children born with ADA-SCID who have been cured using this gene therapy, which will soon be submitted for ...

Discusses Clinical Update on AB8939 Combined With Venetoclax for Refractory and Relapsed AML With Poor Genetics October 16, ...

Lance Alstodt, BioRestorative’s CEO, and Francisco Silva, the Company’s Vice President of Research and Development, will be participating in a panel titled “Stem Cell Therapy – A Space That is Ready ...

As spring unfolds, these are the stories that stayed with me, from mystery to memoir, and everything in between.

When new University of Utah Health CEO Bob Carter isn't overseeing a vast medical network, you can find him in the operating ...

CRISPR Therapeutics’ stock is surging as in-vivo therapies show promise. Learn about CRSP stock's risks, long-term upside, ...

Many born with the genetic disorder thalassaemia major die before the age of 10. Donated blood can help keep them alive.

Visionary Holdings Inc. ("GV" or the "Company"), a technology-driven multinational enterprise listed on Nasdaq ...

Cell International, Inc. (NYSE American LLC Symbol: CCEL) (the "Company", "Cryo-Cell"), the world’s first private cord blood bank to separate and store stem cells in 1992, announced results for the ...